Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis
E.-M. Duerr(Center for Cancer Research), Daniel C. Chung(Massachusetts General Hospital), Yusuke Mizukami(Asahikawa Medical College Hospital), Aylwin Ng(Broad Institute), Vikram Deshpande(Beth Israel Deaconess Medical Center), Matthew H. Kulke(Moffitt Cancer Center), Jonathan N. Glickman(Massachusetts General Hospital), Ramnik J. Xavier(Massachusetts General Hospital), Hirotoshi Kikuchi(Massachusetts General Hospital), Andrew L. Warshaw(Harvard University)
Cited by 98
Related Papers
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T <sub>reg</sub> Cell Homeostasis
|Science|2013|5.3k
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
|Cell Host & Microbe|2014|3.3k
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
|Genome biology|2012|2.8k
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k